Eight parameters to optimize your “Path to Virtualization” across site- and patient-centric capabilities in this Sponsor Edition eBook
Your Path to Virtualization
Sponsor Edition
The COVID-19 pandemic drove 45% of clinical trial sites to transition patients from in-person to remote visits using virtual trial solutions.¹ The urgency to adapt to evolving requirements for both patients and sites is accelerating the adoption of virtualization technologies.
This eBook provides eight parameters to help optimize your path to virtualization across key site- and patient-centric capabilities. To learn more about the capabilities driving a successful response and approach to virtualization, download the eBook now.
[1] http://www.medidata.com/en/insight/covid-19-and-clinical-trials-the-medidata-perspective/#covid-survey
Offered Free by: Medidata, a Dassault Systèmes company
See All Resources from: Medidata, a Dassault Systèmes company
Thank you
This download should complete shortly. If the resource doesn't automatically download, please, click here.
Thank you
This download should complete shortly. If the resource doesn't automatically download, please, click here.